KRAS and clear cell adenocarcinoma: We also observed 20% (4/20) of endometrioid tumors with mutations in KRAS. Mutations in PIK3CA and ARID1A are the most frequent alteration in clear cell carcinomas found in combination in 2/5 (40%) of all CCC tumors in the present study.